|Bioanalytical Systems Inc.|
2701 Kent Avenue
United States - Map
Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
|Ms. Jacqueline M. Lemke ,
Chief Exec. Officer, Pres and Director
|Mr. Jeffrey Potrzebowski CPA,
Chief Financial Officer and VP of Fin.
|Dr. James Sevall Bourdage Ph.D.,
VP of Bioanalytical Operations
|Mr. Larry S. Boulet ,
Director, Chairman of Audit Committee and Member of Nominating/Corp. Governance Committee
|Dr. A. Charlene Sullivan Ph.D.,
Director, Chairman of Nominating/Corp. Governance Committee and Member of Audit Committee
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|